Pay in 4 interest-free payments of $6.97 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
& Rorsman, P
Symptoms often improve as the body adapts to treatment and dose stabilisation
These effects are why BPC 157 is commonly discussed in relation to tendon injuries, ligament recovery, gut health, wound repair, and inflammation control
Learn More First shipment within 1 business day with FREE standard shipping
Protocol 1: the gentle start (for GI-sensitive individuals) Goal: Minimize side effects completely while building to a therapeutic dose Best for: People with histories of medication sensitivity, IBS, acid reflux, or those who tried standard tirzepatide and could not tolerate it Complete schedule: Weeks 1-2: 0.125 mg weekly Weeks 3-4: 0.25 mg weekly Weeks 5-6: 0.5 mg weekly Weeks 7-8: 0.75 mg weekly Weeks 9-10: 1.0 mg weekly Weeks 11-14: 1.5 mg weekly Weeks 15-18: 2.0 mg weekly Weeks 19-22: 2.5 mg weekly Weeks 23-26: 5.0 mg weekly Time to therapeutic dose: 22-26 weeks Expected results: Minimal GI discomfort, gradual appetite reduction beginning around weeks 7-10, meaningful weight loss starting around weeks 15-18 This protocol takes nearly six months to reach 5 mg, but for someone who previously abandoned treatment due to side effects, six months on treatment beats three weeks of misery followed by quitting
This is because antibodies against GPCRs have a notorious lack of specificity (7780), and antibodies for the GLP-1R are no exception (81)
